Europe

This archive covers progress stories from across Europe, spanning the U.K., Scandinavia, the E.U. and beyond. Readers will find reporting on health, climate policy, social welfare, science and more — drawn from nearly 1,200 articles tracking real gains made by communities, governments and researchers throughout the region.

A medical professional reviewing cancer treatment data for an article about cervical cancer survival

U.K. scientists cut cervical cancer death risk by 35% in major trial

Cervical cancer survival rates could improve dramatically after a major clinical trial found that adding a short course of chemotherapy before standard treatment reduces the risk of death or recurrence by 35%. Led by University College London researchers and funded by Cancer Research U.K., the trial showed 80% of women using the new approach were alive at five years, compared to 72% receiving standard treatment alone. The finding is considered the biggest advance in cervical cancer outcomes in over 20 years. Crucially, the drugs involved are already approved, widely available, and inexpensive, meaning the protocol could be adopted globally without new approvals or manufacturing delays.